特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921926

移植診断の世界市場:成長・動向・予測(2020年~2025年)

Transplant Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.37円
移植診断の世界市場:成長・動向・予測(2020年~2025年)
出版日: 2020年01月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

移植診断は、移植前、移植中、および移植後に関連するさまざまな側面の評価に必要とされています。移植は、末期腎疾患患者や慢性透析患者の多くにとって好ましい治療のひとつです。末期腎疾患の有病率は高く、症状が進行した後期で診断されることがあります。移植診断は、ドナーと患者の両者に行われます。技術進歩と共に、先進国の総合専門病院で実施される移植手術の件数が増加しているほか、政府や民間団体の協力によって資金調達の機会が増えています

当レポートでは、世界の移植診断市場を調査し、市場の概要、技術・製品・タイプ・用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長要因
    • 移植手術の発展
    • 移植診断における技術的支援
    • 標的疾患の研究に対する政府と民間の協力
  • 市場の阻害要因
    • 移植コストの高さ
    • 保険および償還制度
    • 臓器移植に関連する社会的および倫理的問題
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 技術別
    • 分子
    • 非分子
  • 製品別
    • 機器
    • 試薬
    • ソフトウェア
  • タイプ別
    • 固形臓器移植
    • 幹細胞移植
    • 軟組織移植
  • 用途別
    • 診断
    • 研究
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Biomerieux SA
    • Bio-Rad Laboratories Inc
    • CareDx
    • F. Hoffman-La Roche Limited
    • Hologic
    • Illumina
    • Qiagen
    • Thermo Fisher Scientific, Inc.

第7章 市場機会および将来動向

目次
Product Code: 67617

Market Overview

Transplantation is among the preferred treatment option for many of the patients suffering from end-stage renal disease, and undergoing chronic dialysis therapy. There is a significant prevalence of patients suffering from end-stage renal disorders, for which the patients are being diagnosed at the later stage of the disease. In the past decade, the diagnostics have improved significantly with companies committed to developing better HLA typing technologies, antibody monitoring, instrument and software. Along with technological advancements, there are a growing number of transplant procedures being performed by the multispeciality hospitals in the developed markets and growing funding opportunities provided by the government and private collaborations. The diagnosis in transplants is done at both the donor and patients end to analyze the infection level inside the organ. However, some of the limitations include the high cost of transplants, insurance, and reimbursement policies, and social and ethical issues related to organ transplants.

Scope of the Report

The transplant diagnostics is necessary for the assessment of different aspects associated with a transplant during a pre-, peri-, and post-transplantation. The scope of the market report consists of segmentation by technology, product, transplant type, application, and geography.

Key Market Trends

Solid Organ Transplant Dominates the Market Segmentation by Transplant Type, Over the Forecast Period

Solid-organ transplantation, which started as an experimental approach in the 20th century is now considered as well-established and practical definitive treatment option for patients suffering from end-stage organ dysfunction. The major number of transplants done for kidney, followed by liver. Some of the technologies used during solid organ transplants include the emergence of molecular diagnostics. However, the greatest yield is obtained from PCR based techniques, which are widely accepted and used across the world. There is no gold standard for the transplant diagnostics, however, there are certain guidelines and tests recommended by the World Health Organization before and after the transplant procedures related to chronic advanced kidney diseases. The other transplants type is still in an experimental stage of development which is expected to grow at a healthy rate over the forecast period.

North America is Expected to Dominate the Market Among Other Regions, over the Forecast Period

Countries such as the United States and Canada are well-equipped with the funded organizations, infrastructure, as well as government participation in raising funds and awareness to promote transplantation of the diseased organs of the patients. There are several initiatives and awareness programs conducted by companies such as Roche collaborating with hospitals, organizations like the American Transplant Foundation to boost the organ donor rate. These companies are advanced in marketing new products for faster diagnostics of diseases before and after the transplants which are well accepted by the private organizations and government of the United States and Canada. Although there are more than 0.1 million awaiting transplants, mostly for kidney, there has been a steady rise in the number of liver donor rates followed by the deceased donor rate, which shows the improvement and demand of more diagnostics facilities across the healthcare facilities related to transplant. With a large section of the population across the world approach these two nations for better healthcare facilities, the region is expected to be very lucrative for growth and dominance over the forecast period.

Competitive Landscape

The technological advancement in terms of reagents effectiveness and affordability, clinicians decision making, as well as raising awareness and proper organ preservation facilities, are some of the present-day opportunities and challenges which the companies are expected to overcome, over the forecast period. Some of the major companies expanding in transplant diagnostics include Abbott Laboratories, Biomerieux SA, F Hoffmann La Roche, Qiagen, and ThermoFisher Scientific, among the rest.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Transplant Procedures
    • 4.2.2 Technological Advacements in Transplant Diagnostics
    • 4.2.3 Government and Private Collaboration into Funding Research of Target Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Transplant
    • 4.3.2 Insurance and Reimbursement Policies
    • 4.3.3 Social and Ethical Issues Related to Organ Transplant
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Molecular
      • 5.1.1.1 PCR based Molecular Assays
      • 5.1.1.2 Sequencing Based Molecular Assays
    • 5.1.2 Non-Molecular
  • 5.2 By Product
    • 5.2.1 Instrument
    • 5.2.2 Reagent
    • 5.2.3 Software
  • 5.3 By Transplant Type
    • 5.3.1 Solid Organ Transplant
    • 5.3.2 Stem Cell Transplant
    • 5.3.3 Soft Tissue Transplant
  • 5.4 By Application
    • 5.4.1 Diagnostic Applications
    • 5.4.2 Research Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 France
      • 5.5.2.2 Germany
      • 5.5.2.3 United Kingdom
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Biomerieux SA
    • 6.1.4 Bio-Rad Laboratories Inc
    • 6.1.5 CareDx
    • 6.1.6 F. Hoffman-La Roche Limited
    • 6.1.7 Hologic
    • 6.1.8 Illumina
    • 6.1.9 Qiagen
    • 6.1.10 Thermo Fisher Scientific, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.